Cancer Research

eBook: Insight into the latest oncology innovation

6 May 2022

This 26-page DDW eBook, sponsored by The Jackson Laboratory, contains exclusive insight from industry experts on: How machine learning is currently used across different stages of cancer research Accelerating research: the path forward for treating rare cancers Immunotherapy challenges and the tools for research Why combination immunotherapies are one of the most exciting ATMPs being […]

Merck & Pfizer’s bladder cancer drug gets NICE approval  

12 April 2022

The National Institute for Health and Care Excellence (NICE) has overturned a previous decision where it chose not to recommend the immunotherapy BAVENCIO (avelumab) for the treatment of bladder cancer.  The decision comes after avelumab’s developers, Merck KGaA and Pfizer, appealed the prior Final Appraisal Document (FAD) by NICE. Avelumab is now recommended as a maintenance […]

This week in DDW – oncology focus

8 April 2022

DDW Deputy Editor Reece Armstrong takes a look at some of the biggest developments that took place within oncology this week (4 April – 8 April).  Scientists win award for transforming breast cancer treatment  A team of scientists from The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust has won a […]

Redx collaborates with Garvan on cancer project  

7 April 2022

Biotechnology company RedX is collaborating with the Garvan Institute of Medical Research on a project investigating novel therapeutic targets in cancer-associated fibrosis.  The collaboration aims to better understand treatments that could lead to increased patient survival in currently very poorly treated highly fibrotic cancers, such as pancreatic cancer.   Redx and Garvan will work on developing […]

London research centre aims to target “undruggable” cancers  

7 April 2022

A new research centre has been established in London to help discover new approaches to treating cancer.   The Centre for Protein Degradation will be based in The Institute of Cancer Research (ICR) in London and will focus on targeted protein degradation to help researchers discover new research tools and treatments for hard-to-treat cancers.  The centre […]

Scientists win award for transforming breast cancer treatment  

5 April 2022

A team of scientists in the UK has been awarded for its work in transforming a breast cancer treatment.  The researchers at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust were named winners of the Team Science Award from the American Association for Cancer Research (AACR).  The team was awarded […]

Interview: What an FDA approval means for immunotherapies  

28 March 2022

DDW Deputy Editor Reece Armstrong speaks to Professor Frederic Triebel, CSO of Immutep about the approval of Bristol Myers Squibb’s LAG-3 antibody and why it’s causing so much excitement in the sector.    Recently, the Food and Drug Administration (FDA) approved the first combination therapy to block the immune checkpoint receptor protein LAG-3 – a move which is […]

Can cannabis and mushroom-based products eliminate colon cancer cells?

8 March 2022

Cannabotech, a biomedical company developing oncological products based on cannabis and mushroom extracts, reports cell model study results showing that its ‘integrative-colon’ products killed over 90% of colon cancer cells. These products are based on a combination of several cannabinoids from the cannabis plant and various mushroom extracts. The study examined the effect of Cannabotech’s […]

Immunotherapy challenges and tools for research 

21 February 2022

Sonia Marsilio is an Associate Product Manager at Enzo. She explains how research tools enable scientists to accelerate immunotherapy.  The growing, continuously evolving arsenal of cancer immunotherapies has changed the treatment landscape of many tumours. Dominating the space are the CAR T cell therapies, with CD19, BCMA, and CD22 as the top targets for haematological malignancies and undisclosed tumour-associated antigen […]

Close the care gap: World Cancer Day 2022 

4 February 2022

2022’s World Cancer Day theme is “Close the Care Gap”1 and is focused on raising awareness of the cancer care equity gap that affects almost everyone, in high as well as low- and middle-income countries, and costs lives. DDW’s Megan Thomas comments on the crisis as well as initiatives that are working to close this gap.  World Cancer Day is a […]

Next »

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free